Exsilio debuts with $82M, pitching a ‘leap’ forward for genetic medicine
Bio Pharma Dive
JUNE 25, 2024
The company claims it can address some of the field’s limitations with medicines delivered via messenger RNA and lipid nanoparticles.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Bio Pharma Dive
JUNE 25, 2024
The company claims it can address some of the field’s limitations with medicines delivered via messenger RNA and lipid nanoparticles.
Pharmaceutical Technology
MARCH 6, 2024
Demand for medicinal cannabis is increasing globally to treat a range of illnesses and conditions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JUNE 27, 2024
A growing cohort of biotechs, from Biohaven to Neurocrine to Jazz, hope research on ion channels will bring them new drugs and big business — much like it has done for Vertex.
Pharmaceutical Technology
MAY 18, 2023
The European Medicines Agency (EMA) has published recommendations to increase communication and planning efforts in a bid stop the current medicine shortages becoming even worse. The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain.
Pharmaceutical Technology
APRIL 24, 2023
Traditional medicine refers to the knowledge, skills and practices that indigenous and different cultures use to maintain health, encompassing forms such as herbal medicine, Traditional Chinese Medicine (TCM) and acupuncture. Studying the behaviour of animals can aid in drug discovery research too.
Bio Pharma Dive
SEPTEMBER 27, 2023
The Swiss drugmaker is restocking its pipeline by buying into preclinical Ionis medicines for Alzheimer’s and Huntington’s diseases.
Pharmaceutical Technology
OCTOBER 26, 2023
The EC announced new initiatives to tackle critical medicine shortages in winter, introducing more flexibility to strengthen supplies.
Pharmaceutical Technology
MARCH 27, 2023
Regenerative medicines in early-stage development (preclinical, discovery, or investigational new drug [IND]/ clinical trial application [CTA] filed status) have seen a change in drug targets compared to therapies in late-stage development (Phase II to pre-registration stage).
Pharmaceutical Technology
MAY 21, 2024
Glenmark has entered into an exclusive agreement with BeiGene to market and distribute two Beigene oncology medicines in India.
Pharmaceutical Technology
FEBRUARY 28, 2024
Regulatory standards concerning raw material selection are particularly stringent when it comes to Regenerative Medicines.
Pharmaceutical Technology
MAY 30, 2024
The EC has granted orphan medicinal product designation for Rocket Pharmaceuticals’ RP-A601 for PKP-2 related arrhythmogenic cardiomyopathy.
Pharmaceutical Technology
MAY 9, 2024
A research project between DMU and the University of Surrey received a grant to help reduce costs for companies in developing medicines.
Pharmaceutical Technology
MAY 23, 2023
The US Food and Drug Administration (FDA) has granted approval for Blueprint Medicines’ Ayvakit (avapritinib) as the first and only treatment for indolent systemic mastocytosis (ISM) in adult patients. The precision therapy has been designed for potently and selectively inhibiting KIT D816V, which is the main underlying driver of the disease.
pharmaphorum
JUNE 13, 2024
In a conversation held earlier in the year as the four-year anniversary of the pandemic approached, the pharmaphorum podcast had as guest Murray Aitken, executive director of the IQVIA Institute for Human Data Science, to discuss the state of global medicines and the future outlook when it comes to research and development, and usage and spending appetites. (..)
Pharmaceutical Technology
OCTOBER 12, 2023
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published updated guidance on valproate-containing medicines.
Bio Pharma Dive
OCTOBER 24, 2023
Rampart Biosciences closed a Series A round that will fund its goal to develop more potent DNA-based medicines that avoid immune responses.
Outsourcing Pharma
JUNE 27, 2024
Personalized medicine has evolved to the point where it is transforming areas of healthcare, bringing hope to patients across the world.
pharmaphorum
JANUARY 11, 2024
In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.
Pharmaceutical Technology
JUNE 18, 2024
CAR-T Cell Therapy is under clinical development by Shanghai Unicar-Therapy Bio-Medicine Technology and currently in Phase II for Diffuse Large B-Cell Lymphoma.
Pharmaceutical Technology
JANUARY 31, 2024
Regeneron Pharmaceuticals has formed Regeneron Cell Medicines, a new research & development (R&D) unit in oncology and immunology.
Pharmaceutical Technology
DECEMBER 23, 2022
Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology.
Outsourcing Pharma
MARCH 26, 2024
Under the agreement, Closed Loop Medicine â a leading TechBio company â and pharmaceutical company, Teva UK, will investigate opportunities to use Closed Loop Medicineâs proprietary software as a medical device (SaMD) technology platform.
Pharmaceutical Technology
JANUARY 25, 2024
We speak with BAP Pharma to learn more about the challenges and possible benefits of medicines access solutions.
Pharmaceutical Technology
APRIL 18, 2024
Discover the groundbreaking multi-domain active protein patented by Huadong Medicine Co Ltd for treating metabolic diseases. With increased efficacy and simplified preparation process, this protein is set to revolutionize existing treatments.
Drug Patent Watch
MARCH 7, 2024
LACTOSE-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Lactose-Free Medicines from Amazon This guide is designed to provide information for healthcare providers to… The post LACTOSE-Free Medicines: Which Drugs Contain LACTOSE?
Drug Patent Watch
MARCH 6, 2024
GELATIN-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Gelatin-Free Medicines on Amazon This guide is designed to provide information for healthcare providers to… The post GELATIN-Free Medicines: Which Drugs Contain GELATIN?
Bio Pharma Dive
SEPTEMBER 22, 2023
Results show that the medicine helped patients who progressed on earlier-line treatments live longer than those receiving chemotherapy without their disease getting worse, according to a Friday announcement.
Pharmaceutical Technology
JANUARY 9, 2024
BIOS Health has partnered with the City of Bakersfield, Kern County, and Kern Venture Group to set up a precision medicine centre in the US.
Pharmaceutical Technology
JANUARY 2, 2024
PYC Therapeutics has announced plans to enter a collaboration with Google Cloud for the development of new precision medicines.
pharmaphorum
MARCH 27, 2024
Teva UK has joined forces with techbio company Closed Loop Medicine to develop digital companions for pharma products that could provide personalised medicine
BioSpace
MARCH 20, 2024
Mirador Therapeutics emerged from stealth Thursday with financing from ARCH Venture Partners and Sanofi, among others, to provide precision medicines for inflammatory and fibrotic diseases.
Pharmaceutical Technology
JANUARY 3, 2024
The UK MHRA has introduced the International Recognition procedure (IRP), a new pathway for medicine approvals.
pharmaphorum
APRIL 15, 2024
The advancement of medicine is dependent on secure pharmaceutical supply chains. Discover why ensuring the security of these chains is crucial for the development and distribution of life-saving medications.
Pharmaceutical Technology
NOVEMBER 8, 2023
NICE is also working on incorporating real-world and AI-generated evidence into medicine evaluation submissions.
Pharmaceutical Technology
JANUARY 17, 2024
In a report, findings suggested that cancer patients in the Netherlands will face longer waits to access new oncology medicines.
Pharmaceutical Technology
JUNE 8, 2023
Biotechnology company Hopewell Therapeutics has raised $25m in seed financing to accelerate the development of next-generation lipid nanoparticles for targeted delivery of genomic medicines. Hopewell Therapeutics is engaged in discovering, synthesising and developing advanced ttLNPs to provide next-generation genomic medicines.
Outsourcing Pharma
MAY 29, 2024
UK based Celadon Pharmaceuticals Plc, that specializes in the development, production, and sale of breakthrough cannabis-based medicines, announced that it has begun shipping to the US.
pharmaphorum
MARCH 12, 2024
Discover why gut bacteria are considered the next frontier in medicine in this informative article. Learn about the importance of the microbiome, its impact on health, and how it relates to conditions like Clostridiales difficile.
Pharmaceutical Technology
OCTOBER 25, 2023
A blockchain system intended to ensure the safety and authenticity of medicines across the supply chain could change the way that medical professionals work, as discussed at the 11th Annual Clinical Trial Supply Nordics conference.
Pharmaceutical Technology
AUGUST 2, 2023
Revolution Medicines has signed a definitive agreement to acquire biopharmaceutical company EQRx in an all-stock transaction.
Pharmaceutical Technology
JANUARY 4, 2024
(Amlodipine + indapamide + telmisartan) is under clinical development by George Medicines and currently in Phase III for Hypertension.
Pharmaceutical Technology
FEBRUARY 27, 2023
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the refusal of the marketing authorisation for Me rck and Ridgeback Biotherapeutics’ Lagevrio (molnupiravir).
BioSpace
MAY 12, 2024
Medicines that address the causative disease biology underlying central nervous system We are in an unprecedented time in neurotherapeutics.
AuroBlog - Aurous Healthcare Clinical Trials blog
APRIL 8, 2024
The Drugs Technical Advisory Board (DTAB) has suggested to the ministry of health and family welfare (MoHFW) to write to the ministry of corporate affairs to mandate the pharma companies to spend almost one per cent of their net profit for providing free medicines in medicine banks as part of the Corporate Social Responsibility (CSR). […]
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content